|
STOCKHOLDERS' DEFICIENCY (Details) (USD $)
|
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
| Stock-based compensation expenses | $ 340,200 | $ 380,000 | $ 1,010,700 | $ 1,225,400 |
|
Neurometric Services Revenue [Member]
|
||||
| Stock-based compensation expenses | 2,500 | 2,500 | 7,600 | 7,600 |
|
Research [Member]
|
||||
| Stock-based compensation expenses | 24,000 | 28,900 | 75,200 | 170,400 |
|
Product Development [Member]
|
||||
| Stock-based compensation expenses | 19,000 | 16,900 | 53,600 | 50,800 |
|
Selling and Marketing Expense [Member]
|
||||
| Stock-based compensation expenses | 49,500 | 48,800 | 147,400 | 160,200 |
|
General and Administrative Expense [Member]
|
||||
| Stock-based compensation expenses | $ 245,200 | $ 282,900 | $ 726,900 | $ 836,400 |